STAT5B and breast cancer: Since Stat5 has been associated with response to anti-estrogen therapy in clinical breast cancer specimens [16,17], this synergistic stimulation of proliferation with estrogen may be a mechanism behind increased responsiveness to anti-estrogen treatments.